Five days of oral topotecan (Hycamtin), a phase I and pharmacological study in adult patients with solid tumours.
Gerrits CJ, Burris H, Schellens JH, Planting AS, van den Burg ME, Rodriguez GI, van Beurden V, Loos WJ, Hudson I, Fields S, Verweij J, von Hoff DD.
Gerrits CJ, et al. Among authors: verweij j.
Eur J Cancer. 1998 Jun;34(7):1030-5. doi: 10.1016/s0959-8049(97)10173-3.
Eur J Cancer. 1998.
PMID: 9849451
Clinical Trial.